Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic

Abstract–The COVID-19 pandemic has had and continues to have major impacts on planned and ongoing clinical trials. Its effects on trial data create multiple potential statistical issues. The scale of impact is unprecedented, but when viewed individually, many of the issues are well defined and feasible to address. A number of strategies and recommendations are put forward to assess and address issues related to estimands, missing data, validity and modifications of statistical analysis methods, need for additional analyses, ability to meet objectives and overall trial interpretability.

[1]  Anna Tostevin,et al.  An observational multi-cohort study on the use and safety of Combivir scored tablets among HIV-infected children and adolescents. Report to the European Medicines Agency (EMA)/ Committee for Medicinal Products for Human Use (CHMP) , 2014 .

[2]  Daniel L. Gillen,et al.  Robust inference in discrete hazard models for randomized clinical trials , 2012, Lifetime Data Analysis.

[3]  Carl van Walraven,et al.  Time-dependent bias was common in survival analyses published in leading clinical journals. , 2004, Journal of clinical epidemiology.

[4]  Tim Friede,et al.  On estimands and the analysis of adverse events in the presence of varying follow‐up times within the benefit assessment of therapies , 2018, Pharmaceutical statistics.

[5]  Kaspar Rufibach,et al.  Treatment effect quantification for time‐to‐event endpoints–Estimands, analysis strategies, and beyond , 2017, Pharmaceutical statistics.

[6]  K. Tilling,et al.  Comparison of imputation variance estimators , 2014, Statistical methods in medical research.

[7]  Bohdana Ratitch,et al.  Clinical Trials with Missing Data: A Guide for Practitioners , 2014 .

[8]  Roderick J. A. Little,et al.  Statistical Analysis with Missing Data: Little/Statistical Analysis with Missing Data , 2002 .

[9]  L. Hunt,et al.  Missing Data in Clinical Studies , 2007 .

[10]  Fang Chen,et al.  Use of historical control data for assessing treatment effects in clinical trials , 2014, Pharmaceutical statistics.

[11]  Michael Schomaker,et al.  Bootstrap inference when using multiple imputation , 2016, Statistics in medicine.

[12]  Gernot Wassmer,et al.  Group Sequential and Confirmatory Adaptive Designs in Clinical Trials , 2016 .

[13]  Nicole A. Lazar,et al.  Statistical Analysis With Missing Data , 2003, Technometrics.

[14]  Bohdana Ratitch,et al.  Missing data in clinical trials: from clinical assumptions to statistical analysis using pattern mixture models , 2013, Pharmaceutical statistics.

[15]  Daniel L Gillen,et al.  Estimation of treatment effect under non‐proportional hazards and conditionally independent censoring , 2012, Statistics in medicine.

[16]  Liang Li,et al.  On the propensity score weighting analysis with survival outcome: Estimands, estimation, and inference , 2018, Statistics in medicine.

[17]  Geert Molenberghs,et al.  Estimands, Estimators and Sensitivity Analysis in Clinical Trials , 2019 .

[18]  James R Carpenter,et al.  Analysis of Longitudinal Trials with Protocol Deviation: A Framework for Relevant, Accessible Assumptions, and Inference via Multiple Imputation , 2013, Journal of biopharmaceutical statistics.

[19]  G. Molenberghs,et al.  Aligning Estimators With Estimands in Clinical Trials: Putting the ICH E9(R1) Guidelines Into Practice. , 2019, Therapeutic innovation & regulatory science.

[20]  H. Schäfer,et al.  A general statistical principle for changing a design any time during the course of a trial , 2004, Statistics in medicine.

[21]  Martin Poscha,et al.  Unplanned adaptations before breaking the blind , 2012, Statistics in Medicine.

[22]  R. Little,et al.  The prevention and treatment of missing data in clinical trials. , 2012, The New England journal of medicine.

[23]  Arnošt Komárek,et al.  Survival Analysis with Interval-Censored Data: A Practical Approach with Examples in R, SAS, and BUGS , 2017 .

[24]  Lena Osterhagen,et al.  Multiple Imputation For Nonresponse In Surveys , 2016 .

[25]  Meinhard Kieser,et al.  Simple procedures for blinded sample size adjustment that do not affect the type I error rate , 2003, Statistics in medicine.